Антирак. Новый образ жизни

   40. Ooi, V. E., and F. Liu, “Immunomodulation and Anti-Cancer Activity of Polysaccharide-Protein Complexes,” Current Medicinal Chemistry 7, no. 7 (2000): 715-29.

   41. Torisu, M., Y. Tayashi, T. Ishimitsu, et al., “Significant Prolongation of Disease-Free Period Gained by Oral Polysaccharide K (PSK) Administration After Curative Surgical Operation of Colorectal Cancer,” Cancer Immunology Immunotherapy 31 (1999): 261-68.

   42. Nakazato, H., A. Koike, S. Saji, et al., “Efficacy of Immunochemotherapy as Adjuvant Treatment After Curative Resection of Gastric Cancer,” Lancet 343 (1994): 1122-26.

   43. Hara, M., T. Hanaoka, M. Kobayashi, et al., “Cruciferous Vegetables, Mushrooms, and Gastrointestinal Cancer Risks in a Multicenter, Hospital-Based Case-Control Study in Japan,” Nutrition and Cancer 46, no. 2 (2003): 138-47.

   44. Torisu, Tayashi, Ishimitsu, et al., “Significant Prolongation of Disease-Free Period . . . ”

   45. Kikuchi, Y., I. Kizawa, K. Oomori, et al., “Effects of PSK on Interleukin-2 Production by Peripheral Lymphocytes of Patients with Advanced Ovarian Carcinoma During Chemotherapy,” Japanese Journal of Cancer Research 79, no. 1 (1988): 125-30.

   46. Tsujitani, S., Y. Kakeji, H. Orita, et al., “Postoperative Adjuvant Immunochemotherapy and Infiltration of Dendritic Cells for Patients with Advanced Gastric Cancer,” Anticancer Research 12, no. 3 (1992): 645-48.

   47. Kariya, Y., N. Inoue, T. Kihara, et al., “Activation of Human Natural Killer Cells by the Protein-Bound Polysaccharide PSK Independently of Interferon and Interleukin 2,” Immunology Letters 31, no. 3 (1992): 241-45.

   48. Mizutani, Y., and O. Yoshida, “Activation by the Protein-Bound Polysaccharide PSK (Krestin) of Cytotoxic Lymphocytes That Act on Fresh Autologous Tumor Cells and T24 Human Urinary Bladder Transitional Carcinoma Cell Line in Patients with Urinary Bladder Cancer,” Journal of Urology 145, no. 5 (1991): 1082-87.

   49. Torisu, Tayashi, Ishimitsu, et al., “Significant Prolongation of Disease-Free Period . . .”

   50. Labrecque, L., S. Lamy, A. Chapus, et al., “Combined Inhibition of PDGF and VEGF Receptors by Ellagic Acid, a Dietary-Derived Phenolic Compound,” Carcinogenesis 26, no. 4 (2005): 821-26.

   51. Ibid.

   52. Hanausek, M., Z. Walaszek, and T. J. Slaga, “Detoxifying Cancer Causing Agents to Prevent Cancer,” Integrative Cancer Therapies 2, no. 2 (2003): 139-44.

   53. Seeram, N., L. Adams, Y. Zhang, et al., “Blackberry, Black Raspberry, Blueberry, Cranberry, Red Raspberry, and Strawberry Extracts Inhibit Growth and Stimulate Apoptosis of Human Cancer Cells in Vitro,” Journal of Agricultural and Food Chemistry 54 (2006): 9329-39.

   54. Béliveau, R., and D. Gingras, Les aliments contre le cancer.

   55. Stoner, G. D., et al., “Cancer Prevention with Freeze-Dried Berries and Berry Components,” Seminars in Cancer Biology 17, no. 5 (2007): 403-10.

   56. Stoner, G. D., “Commentary—Foodstuffs for Preventing Cancer: The Preclinical and Clinical Development of Berries,” Cancer Prevention Research 187 (2009). DOI: doi: 10.1158/1940-6207.CAPR-08-0226.

   57. Vizzotto, M., “Inhibition of Invasive Breast Cancer Cells by Selected Peach and Plum Phenolic Antioxidants” (PhD diss., Texas A&M University, August 2005).

   58. Altman, L. K., “New Drug Fights Second Kind of Cancer,” New York Times, May 14, 2001.

   59. Folkman J., and R. Kalluri, “Cancer Without Disease,” Nature 427, no. 6977 (2004): 787.

   60. Plouzek, C. A., H. P. Ciolino, R. Clarke, et al., “Inhibition of P-glycoprotein Activity and Reversal of Multidrug Resistance in Vitro by Rosemary Extract,” European Journal of Cancer 35, no. 10 (1999): 1541-45.

   61. Lamy, S., et al., “The Dietary Flavonols Apigenin and Luteolin Inhibit PDGF-Dependent Vascular Smooth Muscle Cell Migration,” Cancer Research, in submission.

   62. Béliveau, R., and D. Gingras, Cuisiner avec les aliments contre le cancer (Outremont, Canada: Trécarré, 2006).

   63. Yokoi, K., T. Sasaki, C. D. Bucana, et al., “Simultaneous Inhibition of EGFR, VEGFR, and Platelet-Derived Growth Factor Receptor Signaling Combined with Gemcitabine Produces Therapy of Human Pancreatic Carcinoma and Prolongs Survival in an Orthotopic Nude Mouse Model,” Cancer Research 65, no. 22 (2005): 10371-80.

   64. Ramesha, A., N. Rao, A. R. Rao, et al., “Chemoprevention of 7,12-Dimethylbenz- [a]anthracene-Induced Mammary Carcinogenesis in Rat by the Combined Actions of Selenium, Magnesium, Ascorbic Acid and Retinyl Acetate,” Japanese Journal of Cancer Research 81, no. 12 (1990): 1239-46.

   65. Ibid.